FDA Rejects More China Drugs; Clue to Uterine Ca Disparity; Cancer-Vax Controversy
(MedPage Today) -- China-based Hutchmed announced receipt of a complete response letter from the FDA, stating that the agency cannot approve the tyrosine kinase inhibitor surufatinib for advanced neuroendocrine tumors without support from a multiregional... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 7, 2022 Category: Hematology Source Type: news

Uterine Cancer Rates Have Been Rising, and New Study Suggests Why
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 6, 2022 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Research, News, Source Type: news

2010 to 2017 Saw Increase in Uterine Cancer Mortality Rates
FRIDAY, May 6, 2022 -- Uterine cancer mortality increased from 2010 to 2017, with larger increases seen for nonendometrioid uterine carcinoma, according to a study published online May 5 in JAMA Oncology. Megan A. Clarke, Ph.D., from the National... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 6, 2022 Category: Pharmaceuticals Source Type: news

Uterine Cancer Rates Have Been Rising, and New Study Suggests Why
Title: Uterine Cancer Rates Have Been Rising, and New Study Suggests WhyCategory: Health NewsCreated: 5/6/2022 12:00:00 AMLast Editorial Review: 5/6/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 6, 2022 Category: Cancer & Oncology Source Type: news

Uterine cancer deaths are rising in the United States, and are highest among Black women
Higher death rates are related to the rising incidence of aggressive subtypes of uterine cancer. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 5, 2022 Category: American Health Source Type: news

Study uncovers clues to rise in uterine cancer death rates
A new study has found clues about what's driving an increase in uterine cancer deaths, particularly among Black women (Source: ABC News: Health)
Source: ABC News: Health - May 5, 2022 Category: Consumer Health News Tags: Health Source Type: news

Ultrasound's accuracy can help with breast cancer treatment decisions
Ultrasound is more accurate for measuring the pathology size of breast tumor...Read more on AuntMinnie.comRelated Reading: Elastography methods vie for spot in breast imaging Classifying lesions on ultrasound helps predict ovarian cancer Out with the old, in with new for uterine bleeding terms, TVUS Ultrasound spots less-aggressive DCIS on breast exams Don't delay mammograms after COVID vaccine (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 1, 2022 Category: Radiology Source Type: news

Echo links low atrial function to dementia later in life
Echocardiography links lower left atrial function -- as opposed to the siz...Read more on AuntMinnie.comRelated Reading: Classifying lesions on ultrasound helps predict ovarian cancer Out with the old, in with new for uterine bleeding terms, TVUS Consensus on sonogram use could help pediatric trauma patients Ultrasound useful for surveillance of small renal masses Ultrasound spots less-aggressive DCIS on breast exams (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 23, 2022 Category: Radiology Source Type: news

Classifying lesions on ultrasound helps predict ovarian cancer
Ultrasound can help predict ovarian cancer in women by classifying adnexal lesion...Read more on AuntMinnie.comRelated Reading: Out with the old, in with new for uterine bleeding terms, TVUS 5 rules for diagnosing fetal problems on ultrasound Ultrasound helps predict difficult vaginal delivery Ultrasound spots less-aggressive DCIS on breast exams Ultrasound on par with MRI to measure myometrial invasion depth (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 22, 2022 Category: Radiology Source Type: news

Changing Landscape of Uterine and Ovarian Cancer in the US Changing Landscape of Uterine and Ovarian Cancer in the US
The landscape of gynecologic cancer in the United States is changing rapidly and the risk of dying from uterine cancer is now similar to that for ovarian cancer among women overall, and roughly 60% higher among Black women, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

RF ablation safe and effective for thyroid tumors
Radiofrequency (RF) ablation is a safe and effective option for patients wit...Read more on AuntMinnie.comRelated Reading: Can cooled RF ablation relieve post-knee replacement pain? RF ablation relieves pain for bone cancer patients in 3 days E/M coding and billing for interventional radiology Is uterine artery embolization underused for postpartum bleeding? US features help define thyroid nodules in children (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 11, 2022 Category: Radiology Source Type: news

Uterine Cancer Patients Are Step Closer to 9/11 Benefits Uterine Cancer Patients Are Step Closer to 9/11 Benefits
The World Trade Center Health Program is considering covering the most common form of uterine cancer, in what patient advocates say is a key acknowledgment of the women affected by the 9/11 fallout.Kaiser Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 13, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves Two New Indications for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease who have...
Source: Johnson and Johnson - December 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Science Saturday: Uterine microbe found to have disease-causing behavior in endometrial cancer
A tiny microbe thriving in the uterine microbiome — a population of bacteria, viruses, yeasts/fungi in and around the uterus— could be a contributing driver of endometrial cancer, according to a new Mayo Clinic study.  "We have found that a microbe that is particularly associated with endometrial cancer is capable of pathogenic behavior, and is stimulated by one of the main risk factors for the disease — estrogen exposure," explains Marina Walther-Antonio, Ph.D.,  a researcher within the Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 4, 2021 Category: Databases & Libraries Source Type: news

NaviFUS to begin FUS terminal brain cancer trial
The Taiwan Food and Drug Administration has approved the use of NaviFUS' focuse...Read more on AuntMinnie.comRelated Reading: MRgFUS shows promise for prostate cancer treatment Philips, InSightec to partner on MRgUS Newer MRgFUS systems work better for uterine fibroids MRgFUS could hurdle Alzheimer's treatment obstacle Focused ultrasound treatment to brain relieves tremors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 4, 2021 Category: Radiology Source Type: news